Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Literature
1.
Ishiyama H, Akiko S, Keiji N, Takaaki H (2004) Relationship between morphine and radiotherapy for management of symptomatic bone metastases from lung cancer. Support Care Cancer 12:743–745CrossRef
2.
Wu JSY, Wong R, Johnston M, Bezjak A, Whelan T, on behalf of the CCO Practice Guidelines Initiative Supportive Care Group (2003) Meta-analyses of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55(3):594–605CrossRef
3.
Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD (2003) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy—a systematic review of randomized trials. Clin Oncol (R Coll Radiol) 13(5):353–355
4.
Chow E, Wu JSY, Hoskin P, Coia LR, Bentzen SM, Blitzer PH (2002) International consensus on palliative radiotherapy endpoints for future clinical trial in bone metastases. Radiother Oncol 64(3)275–280
Metadata
Title
Letter to the Editor
Authors
Meagan Doyle
Elizabeth A. Barnes
Emily Sinclair
Cyril Danjoux
Edward Chow
Publication date
01-03-2005
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 3/2005
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0764-5

Other articles of this Issue 3/2005

Supportive Care in Cancer 3/2005 Go to the issue

Short Communication

Thyrotoxic crisis induced by cytotoxic chemotherapy

Review Article

Advances in opioid pharmacology

Original Article

Symptoms, treatment and “dying peacefully” in terminally ill cancer patients: a prospective study

Review Article

Advances in opioid therapy and formulations

Original Paper

Outcome research in palliative care: could it represent a new dimension of clinical research or clinical practice?

Letter to the Editor

Reply to the comment of Dr. Sbanotto
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits